FindTrial
Sign In

Effectivity of Hydroxy chloroquinine in patients of symptomatic Oral Lichen Planus

To evaluate Efficacy and Safety of Hydroxy chloroquinine in patients of symptomatic Oral Lichen Planus.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/09/015830
Enrollment
30
Registered
2018-09-25
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D899- Disorder involving the immune mechanism, unspecified

Interventions

Intervention1: To evaluate Efficacy and Safety of Hydroxy chloroquinine in patients of symptomatic Oral Lichen Planus: 200 mg two times a day for six month Intervention2: To evaluate Efficacy and Safe

Sponsors

Dr RPGMC Kangra At Tanda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 All Patients Except Exclusion Criteria

Exclusion criteria

Exclusion criteria: 1 Age 2 Asymptomatic oral lesions 3 pregnant or lactating women 4 Use of lichenoid reaction inducing drugs. 5 the presence of amalgam filling close to lesions 6 presence of skin ,genital or other extra oral lesions 7 Chronic liver disease, hematological disease and immune system dysfunction 8 Any other absolute/relative contraindications of use of hydroxyl chloroquine.

Design outcomes

Primary

MeasureTime frame
To evaluate Efficacy and Safety of Hydroxy chloroquinine in patients of symptomatic Oral Lichen Planus Timepoint: after 1 year—

Secondary

MeasureTime frame
Patients Satisfaction And ORAL LICHAN PLANUS Lesion ResolvmentTimepoint: One YEAR—

Countries

India

Contacts

Public ContactDr Megha Sondhi

Dr.R.P.G.M.C Tanda HimachaL Pradesh

drkaranindermehta@gmail.com9418457647

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026